Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиPLx Pharma Мультипликаторы 2011-2024 | PLXP
Мультипликаторы по годам PLx Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.6 | -3.2 | -2.5 | 52.4 | -3.0 | -0.7 | -4.1 | -6.4 | - | - | - |
P/S |
14.4 | 1618.8 | 91.2 | 62.4 | 58.6 | - | - | - | - | - | - |
EPS |
-2.1 | -1.7 | -3.8 | 0.1 | -2.2 | -1.1 | -2.0 | -1.7 | -0.9 | - | - |
EV (Enterprise Value) |
73.8 млн | 64.4 млн | 68.2 млн | 44.7 млн | 45.5 млн | 17.1 млн | 72.7 млн | 60.7 млн | -3.04 млн | 162 тыс. | - |
EBITDA per Share |
-1.72 | -1.42 | -1.58 | -1.23 | -1.91 | -16.5 | -15.9 | -13.8 | - | - | - |
EV/EBITDA |
-1.8 | -2.1 | -3.0 | -3.7 | -2.1 | 0.1 | -3.8 | -4.4 | - | - | - |
PEG |
0.15 | -0.06 | 0.0 | 0.5 | -0.03 | 0.2 | 0.27 | 0.06 | - | - | - |
P/B |
2.3 | -4.5 | -4.3 | 7.3 | 9.9 | 1.0 | 2.5 | 3.3 | - | - | - |
P/CF |
-3.7 | -4.0 | -4.0 | -4.6 | -3.3 | -1.0 | -5.2 | -7.7 | - | - | - |
ROE % |
-129.32 | 139.14 | 169.55 | 13.91 | -332.44 | -142.44 | -60.85 | -52.34 | - | - | - |
ROA % |
-60.18 | -57.15 | -110.81 | 4.88 | -53.20 | -124.75 | -57.83 | -49.91 | - | - | - |
ROCE % |
-114.37 | -58.33 | -114.45 | -80.27 | -50.14 | -142.75 | -60.92 | -52.34 | - | - | - |
Current Ratio |
3.1 | 6.5 | 2.3 | 3.1 | 14.1 | 8.0 | 20.1 | 21.5 | - | - | - |
DSO |
14.1 | - | 12.1 | 8.8 | 9.1 | - | - | - | - | - | - |
DIO |
97.2 | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
111.3 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
111.3 | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально PLx Pharma
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -0.3 | -0.43 | -0.39 | - | -0.8 | -0.79 | -0.73 | - | -0.4 | -0.66 | 0.08 | - | 0.09 | -1.1 | -2.71 | - | -0.39 | -0.41 | 0.57 | - | -0.44 | -0.36 | -0.33 | - | -0.25 | -0.33 | -0.56 | - | -0.49 | -0.47 | -0.49 | - | -0.45 | -0.46 | -0.44 | - | -0.21 | -0.08 | 0.09 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.38 | -0.52 | -0.66 | - | -0.36 | -0.27 | -0.22 | - | -0.34 | -0.38 | -0.32 | - | -0.4 | -0.43 | -0.33 | - | -0.3 | -0.26 | -0.37 | - | -0.45 | -0.69 | -0.31 | - | -0.24 | -0.33 | -0.57 | - | -0.49 | -0.47 | -0.49 | - | -0.45 | -0.46 | -0.44 | - | -0.21 | -0.08 | -0.09 | - | - | - | - | - | - | - | - |
ROE % |
-196.85 | -266.90 | -253.55 | -222.78 | -137.04 | -108.44 | -9.78 | 82.58 | 66.13 | 52.04 | 9.35 | 35.44 | 153.01 | 99.86 | 60.81 | -72.41 | -31.81 | -114.11 | -143.27 | -135.79 | -161.65 | -114.98 | 13.99 | 125.73 | 71.11 | 54.82 | -8.15 | -84.54 | -42.98 | -57.79 | -56.30 | -58.32 | -29.92 | -29.92 | -15.11 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-69.92 | -93.49 | -91.48 | -84.20 | -55.98 | -67.73 | -55.91 | -57.59 | -27.16 | -17.95 | 3.00 | -26.48 | -100.00 | -118.62 | -146.46 | -115.54 | -11.15 | -24.32 | -18.86 | -7.02 | -25.87 | -201.45 | -363.86 | -594.25 | -447.76 | -463.25 | -303.15 | -77.45 | -40.85 | -54.97 | -53.61 | -55.58 | -37.88 | -62.47 | -72.94 | -67.54 | -133.19 | -133.19 | -108.60 | -99.59 | - | - | - | - | - | - | - | - |
ROCE % |
-264.63 | -296.55 | -222.07 | -150.07 | -56.13 | -26.96 | 34.13 | 82.98 | 89.35 | 119.75 | 120.98 | 120.12 | 86.38 | 42.89 | -31.01 | -100.04 | -130.93 | -215.79 | -257.15 | -312.56 | -206.61 | -161.18 | -30.89 | 123.96 | 68.73 | 52.40 | -9.35 | -84.70 | -43.02 | -57.83 | -56.32 | -58.33 | -29.92 | -29.92 | -15.11 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 4.7 | 3.7 | 3.2 | 3.1 | 2.0 | 2.9 | 4.0 | 1.6 | 1.6 | 1.6 | 1.6 | 1.1 | 1.1 | 1.1 | 1.1 | 1.5 | 1.5 | 1.5 | 1.5 | 1.2 | 1.2 | 1.2 | 1.2 | 0.2 | 0.2 | 0.2 | 8.1 | 20.2 | 20.2 | 20.2 | 20.2 | 21.6 | 21.6 | 21.6 | 21.6 | 4.9 | 4.9 | 4.9 | 4.9 | - | - | - | - | - | - | - | - |
DSO |
- | 74.3 | 112.2 | 29.2 | - | 22.4 | - | - | - | - | 4.1 | 383.5 | - | 41.5 | 9.3 | 5.3 | - | 7.7 | 9.9 | 21.1 | - | 28.4 | 4.7 | - | - | 23.2 | 11.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | 220.7 | 429.6 | 245.8 | - | 40.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | 295.0 | 541.9 | 274.9 | - | 62.7 | - | - | - | - | 4.1 | 383.5 | - | 41.5 | 9.3 | 5.3 | - | 7.7 | 9.9 | 21.1 | - | 28.4 | 4.7 | - | - | 23.2 | 11.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | 295.0 | 541.9 | 274.9 | - | 62.7 | - | - | - | - | 4.1 | 383.5 | - | 41.5 | 9.3 | 5.3 | - | 7.7 | 9.9 | 21.1 | - | 28.4 | 4.7 | - | - | 23.2 | 11.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD